Development and External Validation of a Nomogram to Predict Recurrence-Free Survival After R0 Resection for Stage II/III Gastric Cancer: An International Multicenter Study

Background: The benefit of adjuvant chemotherapy varies widely among patients with stage II/III gastric cancer (GC), and tools predicting outcomes for this patient subset are lacking. We aimed to develop and validate a nomogram to predict recurrence-free survival (RFS) and the benefits of adjuvant c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jun, Xu, Bin-bin, Zheng, Chao-hui, Li, Ping, Xie, Jian-wei, Wang, Jia-bin, Lin, Jian-xian, Chen, Qi-yue, Truty, Mark J., Huang, Chang-ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643002/
https://www.ncbi.nlm.nih.gov/pubmed/33194683
http://dx.doi.org/10.3389/fonc.2020.574611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643002/
https://www.ncbi.nlm.nih.gov/pubmed/33194683
http://dx.doi.org/10.3389/fonc.2020.574611

Ejemplares similares